BMS’ Breyanzi gets FDA accelerated approval for follicular lymphoma
The approval is based on results from open-label, global, multicentre, Phase 2, single-arm TRANSCEND FL study in which…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
16 May 24
The approval is based on results from open-label, global, multicentre, Phase 2, single-arm TRANSCEND FL study in which…
15 May 24
Upstaza is a one-time gene replacement therapy intended for patients aged 18 months and older who have a…
15 May 24
The study brings together Verismo's proprietary SynKIR platform and novel CD19 binder to treat CAR-naïve and post-CAR relapsed…
13 May 24
The FDA approval of the cancer vaccine, dubbed WGc-043, represents a significant advance in cancer treatment, supporting patients…
09 May 24
The expansion of the indication is based on data from APL2-308 which assessed Aspaveli over a period of…
08 May 24
The sNDA approval of Zoladex LA 10.8mg introduces a three-month dosing alternative for young women diagnosed with hormone-positive…
30 Apr 24
The full approval is based on positive results from global Phase 3 innovaTV 301 study that showed overall…
30 Apr 24
The approval was based on the findings from the 4WHIM Phase 3 clinical trial in which treatment with…
29 Apr 24
The approval was based on the results from the Phase 3 BENEGENE-2 study in which Beqvez demonstrated non-inferiority…
25 Apr 24
The approval was based on results from three controlled clinical trials of females aged 18 and above in…